296 participants
PROMES: A Clinical Study in Which Researchers Want to Learn More About the Safety Profile of MESIGYNA (Norethisterone Enantate 50 mg and Estradiol Valerate 5 mg) Used as a Medication to Prevent Pregnancy for Adult Women in Reproductive Age in the Peruvian Population at the Outpatient Clinic.
- Study Type:
- OBSERVATIONAL
- Last Updated:
- 2022-12-21
- Start Date:
- 2019-08-26
- Completion:
- 2021-08-31
Conditions
- Contraceptive
Interventions
- DRUG
No Results Yet